Citation Impact
Citing Papers
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
2011
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
2008
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Comparison of an inflammation‐based prognostic score (GPS) with performance status (ECOG‐ps) in patients receiving palliative chemotherapy for gastroesophageal cancer
2007
Imaging in the era of molecular oncology
2008 StandoutNature
Esophageal Cancer
2003 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
2006
Oesophageal carcinoma
2013 Standout
Guidelines for the management of oesophageal and gastric cancer
2011
Gastric cancer
2020 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer
2002
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
2000
Chemotherapy for advanced gastric cancer
2017 Standout
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
2004
Global cancer statistics, 2012
2015 Standout
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma
1996
Works of D.H. Ilson being referenced
Chemotherapy in esophageal cancer
1993
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
1998
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer
2007
Chemotherapy in esophageal cancer.
1999